Emilie Faivre, Alison Hamilton, Christian Hölscher. Eur J Pharmacol 2012
Times Cited: 51
Times Cited: 51
Ziyue Yuan, Dongfang Li, Peng Feng, Guofang Xue, Chenhui Ji, Guanglai Li, Christian Hölscher. Eur J Pharmacol 2017
Times Cited: 60
Times Cited: 60
List of shared articles
Times cited
DAla2-GIP-GLU-PAL Protects Against Cognitive Deficits and Pathology in APP/PS1 Mice by Inhibiting Neuroinflammation and Upregulating cAMP/PKA/CREB Signaling Pathways.
Li Yuan, Jun Zhang, Jun-Hong Guo, Christian Holscher, Jun-Ting Yang, Mei-Na Wu, Zhao-Jun Wang, Hong-Yan Cai, Ling-Na Han, Hui Shi,[...]. J Alzheimers Dis 2021
Li Yuan, Jun Zhang, Jun-Hong Guo, Christian Holscher, Jun-Ting Yang, Mei-Na Wu, Zhao-Jun Wang, Hong-Yan Cai, Ling-Na Han, Hui Shi,[...]. J Alzheimers Dis 2021
Of mice and men: incretin actions in the central nervous system.
Olivia M Farr, Eleni Pilitsi, Christos S Mantzoros. Metabolism 2019
Olivia M Farr, Eleni Pilitsi, Christos S Mantzoros. Metabolism 2019
The Dual GLP-1/GIP Receptor Agonist DA4-JC Shows Superior Protective Properties Compared to the GLP-1 Analogue Liraglutide in the APP/PS1 Mouse Model of Alzheimer's Disease.
Mark Maskery, Elizabeth Mary Goulding, Simon Gengler, Josefine Ulrikke Melchiorsen, Mette Marie Rosenkilde, Christian Hölscher. Am J Alzheimers Dis Other Demen 2020
Mark Maskery, Elizabeth Mary Goulding, Simon Gengler, Josefine Ulrikke Melchiorsen, Mette Marie Rosenkilde, Christian Hölscher. Am J Alzheimers Dis Other Demen 2020
GIP has neuroprotective effects in Alzheimer and Parkinson's disease models.
Zhen Qiang Zhang, Christian Hölscher. Peptides 2020
Zhen Qiang Zhang, Christian Hölscher. Peptides 2020
The Novel DA-CH3 Dual Incretin Restores Endoplasmic Reticulum Stress and Autophagy Impairments to Attenuate Alzheimer-Like Pathology and Cognitive Decrements in the APPSWE/PS1ΔE9 Mouse Model.
Theodora Panagaki, Simon Gengler, Christian Hölscher. J Alzheimers Dis 2018
Theodora Panagaki, Simon Gengler, Christian Hölscher. J Alzheimers Dis 2018
Targeting glucose-dependent insulinotropic polypeptide receptor for neurodegenerative disorders.
Mahip K Verma, Rajan Goel, Nandakumar Krishnadas, Kumar V S Nemmani. Expert Opin Ther Targets 2018
Mahip K Verma, Rajan Goel, Nandakumar Krishnadas, Kumar V S Nemmani. Expert Opin Ther Targets 2018
Neuroprotective and restorative properties of the GLP-1/GIP dual agonist DA-JC1 compared with a GLP-1 single agonist in Alzheimer's disease.
Geisa Nogueira Salles, Michele Longoni Calió, Christian Hölscher, Cristina Pacheco-Soares, Marimelia Porcionatto, Anderson Oliveira Lobo. Neuropharmacology 2020
Geisa Nogueira Salles, Michele Longoni Calió, Christian Hölscher, Cristina Pacheco-Soares, Marimelia Porcionatto, Anderson Oliveira Lobo. Neuropharmacology 2020
DA5-CH, a novel GLP-1/GIP dual agonist, effectively ameliorates the cognitive impairments and pathology in the APP/PS1 mouse model of Alzheimer's disease.
Yue Cao, Christian Hölscher, Meng-Ming Hu, Ting Wang, Fang Zhao, Yu Bai, Jun Zhang, Mei-Na Wu, Jin-Shun Qi. Eur J Pharmacol 2018
Yue Cao, Christian Hölscher, Meng-Ming Hu, Ting Wang, Fang Zhao, Yu Bai, Jun Zhang, Mei-Na Wu, Jin-Shun Qi. Eur J Pharmacol 2018
Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeutics.
Therese S Salameh, Elizabeth M Rhea, Konrad Talbot, William A Banks. Biochem Pharmacol 2020
Therese S Salameh, Elizabeth M Rhea, Konrad Talbot, William A Banks. Biochem Pharmacol 2020
Neuroprotective Actions of Glucagon-Like Peptide-1 (GLP-1) Analogues in Alzheimer's and Parkinson's Diseases.
Andre F Batista, Victor Bodart-Santos, Fernanda G De Felice, Sergio T Ferreira. CNS Drugs 2019
Andre F Batista, Victor Bodart-Santos, Fernanda G De Felice, Sergio T Ferreira. CNS Drugs 2019
Gut hormone polyagonists for the treatment of type 2 diabetes.
Sara J Brandt, Anna Götz, Matthias H Tschöp, Timo D Müller. Peptides 2018
Sara J Brandt, Anna Götz, Matthias H Tschöp, Timo D Müller. Peptides 2018